Actively Recruiting
Led by Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari · Updated on 2025-12-08
84
Participants Needed
1
Research Sites
N/A
Total Duration
This research investigates treatments for patients suffering from Plantar Fasciitis by comparing three different approaches. The study evaluates whether there are differences in outcomes among groups receiving different therapies, focusing on pain and foot function scores. The trial is an early phase 1 interventional study that aims to provide insights into these treatment options. Participants are randomly assigned to one of three groups: one receives an infiltration of 2ml of Collagen Hydrolyzed Peptides near the heel spur, the second group undergoes Extracorporeal Shockwave Therapy (ESWT), and the third group receives a combination of both treatments. The study assesses the effects of these treatments over time. During the study, participants will be monitored for changes in pain using the Visuoanalogic Scale (VAS) and foot function using the American Foot and Ankle Scale (AFAS) at multiple time points between recruitment and up to 60 days. The study observes participants' responses to treatment and evaluates outcomes at 15, 30, and 60 days after recruitment to understand the impact of each therapy.
CONDITIONS
Plantar Fascitiis: Comparison of ESWT and Collagen Hydrolyzed Peptides
You may qualify if you...
You will not qualify if you...
Complete this quick 3-step screening to check your eligibility
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to 60 days
Participants receive one of three treatments: infiltration of collagen hydrolyzed peptides, ESWT (Extracorporeal Shockwave Therapy), or a combination of both treatments.
1 to 3 visits depending on treatment group
Duration - Up to 60 days post-treatment
Participants are monitored for treatment outcomes using pain and function assessments.
Visits at 15, 30, and 60 days post-treatment
Total: 1 location
1
Angela Notarnicola
Bari, Italy, 70124
Actively Recruiting
S
Silvana DE GIORGI, PI
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
3
Have more questions? Get in touch with our team for quick support
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Ta-Wei Lai, Hsiao-Li Ma, Meng-Shiunn Lee...
https://pubmed.ncbi.nlm.nih.gov/29504578Kai Sun, Haiyu Zhou, Wenxue Jiang
https://pubmed.ncbi.nlm.nih.gov/30502222Dingli Xu, Weiyu Jiang, Dichao Huang...
https://pubmed.ncbi.nlm.nih.gov/31744313Haimanot Melese, Abayneh Alamer, Kefale Getie...
https://pubmed.ncbi.nlm.nih.gov/34038642